These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 30362626)
1. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling. Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626 [TBL] [Abstract][Full Text] [Related]
2. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982 [TBL] [Abstract][Full Text] [Related]
3. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma. Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
5. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway. Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
10. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway. Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318 [No Abstract] [Full Text] [Related]
13. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Xie X; Xu X; Sun C; Yu Z Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653 [TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Lan T; Yuan K; Yan X; Xu L; Liao H; Hao X; Wang J; Liu H; Chen X; Xie K; Li J; Liao M; Huang J; Zeng Y; Wu H Cancer Res; 2019 Jul; 79(13):3220-3234. PubMed ID: 31101763 [TBL] [Abstract][Full Text] [Related]
15. LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma. Zhang K; Zhao Z; Yu J; Chen W; Xu Q; Chen L J Cell Biochem; 2018 Jul; 119(7):6045-6056. PubMed ID: 29574975 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo. Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]